Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05111626 | Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.(FORTITUDE-102) | terminated | Phase 3 | 515 | AmgenINDUSTRY | 29 | Sep 10, 2026 | clinicaltrials |
| NCT03042169 | Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer(SURGIGAST) | terminated | Phase 3 | 6 | University Hospital, LilleOTHER |
| 1 |
| Dec 23, 2025 |
| clinicaltrials |
| NCT02867839 | Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer(RESCUE-GC) | terminated | Phase 3 | 29 | Peking University Cancer Hospital & InstituteOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial(DIGEST) | terminated | Phase 3 | 361 | Taiho Oncology, Inc.INDUSTRY | 20 | Sep 19, 2024 | clinicaltrials |
| NCT02076594 | Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer | terminated | Phase 3 | 171 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT02150447 | The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding | terminated | Phase 3 | 394 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 4, 2018 | clinicaltrials |
| NCT01813253 | Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer | terminated | Phase 3 | 400 | Kuhnil Pharmaceutical Co., Ltd.INDUSTRY | 3 | Mar 26, 2018 | clinicaltrials |
| NCT01683864 | Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer(HIPECStomach) | terminated | Phase 2 / Phase 3 | 3 | University Hospital TuebingenOTHER | 1 | Jan 30, 2018 | clinicaltrials |
| NCT01641939 | A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer | terminated | Phase 2 / Phase 3 | 415 | Hoffmann-La RocheINDUSTRY | 28 | May 12, 2017 | clinicaltrials |
| NCT01433861 | Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy(PRAPT) | terminated | Phase 3 | 7 | Seoul National University Bundang HospitalOTHER | 1 | Jan 9, 2017 | clinicaltrials |
| NCT01450696 | A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer(HELOISE) | terminated | Phase 3 | 296 | Hoffmann-La RocheINDUSTRY | 25 | Nov 28, 2016 | clinicaltrials |
| NCT02137343 | A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer(RILOMET-2) | terminated | Phase 3 | 34 | AmgenINDUSTRY | 2 | Apr 4, 2016 | clinicaltrials |
| NCT01697072 | First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma(RILOMET-1) | terminated | Phase 3 | 609 | AmgenINDUSTRY | 27 | Feb 9, 2016 | clinicaltrials |
| NCT01989858 | ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)(ITACA-S2) | terminated | Phase 3 | 1,180 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | terminated | Phase 3 | 42 | Dong-A University HospitalOTHER | 1 | Nov 4, 2014 | clinicaltrials |
| NCT00387348 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | terminated | Phase 3 | 24 | Massachusetts General HospitalOTHER | 1 | Dec 3, 2012 | clinicaltrials |
| NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | terminated | Phase 3 | 144 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00359476 | A Study of Vinflunine in Patients With Gastric Cancer | terminated | Phase 2 / Phase 3 | 55 | Bristol-Myers SquibbINDUSTRY | 3 | Mar 2, 2010 | clinicaltrials |
| NCT00149266 | Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502) | terminated | Phase 3 | 167 | Japan Clinical Oncology GroupOTHER | 1 | Feb 3, 2009 | clinicaltrials |
| NCT00503321 | Phase II Study of TS-1 Therapy and TS-1+PSK Therapy Against Advanced Gastric Carcinoma(eNCIT-Japan) | terminated | Phase 2 / Phase 3 | 13 | Eastern Network of Cancer Immunological Therapy, JapanOTHER | 1 | Jan 23, 2009 | clinicaltrials |
Data updated 19 days agoSource updated Sep 10, 2026source: clinicaltrials